Kakali Ghoshal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kakali Ghoshal has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Ayush Madan
2 shared publicationsDebalina Bhattacharya
2 shared publicationsLeila Dehghani
2 shared publicationsMainak Mukhopadhyay
2 shared publicationsNaimeh Mahheidari
2 shared publicationsSougata Ghosh Chowdhury
2 shared publications
Latest Publications
- 16 May 2026
- Published by Elsevier
- p. 261-295
Stem cells and pyroptosis in atherosclerosis
- 16 May 2026
- Published by Elsevier
Contributors
- 5 April 2024
- Published by Elsevier
- p. 135-165
Exosomal RNA in type 2 diabetes mellitus and other metabolic diseases
- 5 April 2024
- Published by Elsevier
- p. 135-165
Exosomal RNA in type 2 diabetes mellitus and other metabolic diseases
- 5 April 2024
- Published by Elsevier
Contributors
- 1 October 2023
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (10) , 1805-1807
Cardiac Adipocytes: Friends or Foes?
- 1 October 2023
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (10) , 1805-1807
Cardiac Adipocytes: Friends or Foes?
- Top Cited PapersOpen Access
- 3 March 2014
- Published by Wiley in The Scientific World Journal
- Vol. 2014, 1-16
Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis
Platelets are small anucleate cell fragments that circulate in blood playing crucial role in managing vascular integrity and regulating hemostasis. Platelets are also involved in the fundamental biological process of chronic inflammation associated with disease pathology. Platelet indices like mean platelets volume (MPV), platelets distributed width (PDW), and platelet crit (PCT) are useful as cheap noninvasive biomarkers for assessing the diseased states. Dynamic platelets bear distinct morphology, whereαand dense granule are actively involved in secretion of molecules like GPIIb , IIIa, fibrinogen, vWf, catecholamines, serotonin, calcium, ATP, ADP, and so forth, which are involved in aggregation. Differential expressions of surface receptors like CD36, CD41, CD61 and so forth have also been quantitated in several diseases. Platelet clinical research faces challenges due to the vulnerable nature of platelet structure functions and lack of accurate assay techniques. But recent advancement in flow cytometry inputs huge progress in the field of platelets study. Platelets activation and dysfunction have been implicated in diabetes, renal diseases, tumorigenesis, Alzheimer’s, and CVD. In conclusion, this paper elucidates that platelets are not that innocent as they keep showing and thus numerous novel platelet biomarkers are upcoming very soon in the field of clinical research which can be important for predicting and diagnosing disease state.
- 3 March 2014
- Published by Wiley in The Scientific World Journal
- Vol. 2014, 1-16
Top Cited PapersOpen AccessOverview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis
Platelets are small anucleate cell fragments that circulate in blood playing crucial role in managing vascular integrity and regulating hemostasis. Platelets are also involved in the fundamental biological process of chronic inflammation associated with disease pathology. Platelet indices like mean platelets volume (MPV), platelets distributed width (PDW), and platelet crit (PCT) are useful as cheap noninvasive biomarkers for assessing the diseased states. Dynamic platelets bear distinct morphology, whereαand dense granule are actively involved in secretion of molecules like GPIIb , IIIa, fibrinogen, vWf, catecholamines, serotonin, calcium, ATP, ADP, and so forth, which are involved in aggregation. Differential expressions of surface receptors like CD36, CD41, CD61 and so forth have also been quantitated in several diseases. Platelet clinical research faces challenges due to the vulnerable nature of platelet structure functions and lack of accurate assay techniques. But recent advancement in flow cytometry inputs huge progress in the field of platelets study. Platelets activation and dysfunction have been implicated in diabetes, renal diseases, tumorigenesis, Alzheimer’s, and CVD. In conclusion, this paper elucidates that platelets are not that innocent as they keep showing and thus numerous novel platelet biomarkers are upcoming very soon in the field of clinical research which can be important for predicting and diagnosing disease state.